The analysis of invasion associated gene in glioblastoma
The analysis of invasion associated gene in glioblastoma
批准号:
11470286
负责人:
YAMASHITA Junkoh
金额:
$9.47万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We revealed two points as follows. 1)Among proteinases, matrix metalloproteinases(MMPs)are thought to play a key role in the tumor progression through the degradation of extracellular matrix. We examined th role of MMP-2(gelatinase A)and membrane type 1-MMP(MT1-MMP, an activator of the zymogen of MMP-2=proMMP-2)together with their inhibitors, tissue inhibitors of metalloproteinases(TIMP-1 and TIMP-2), in the invasion of human astrocytic tumors. The investigations were performed using sandwich enzyme immunoassay systems, quantitative reverse transcription polymerase chain reaction(RT-PCR), gymography, Immunohistochemistry and cell transfection. The results suggest that MT1-MMP may contribute to the invasion and CSF dissemination of glioblastoma cells on the basis of an imbalance to TIMP-2. 2)Ets transcription factors are associated with tumor malignancy. We analyzed effects of Ets-DN-expression on cell adhesion, migration and phosphorylation of focal adhesion kinase(FAK). U251 cells expressing Ets-DN(U251-DN)showed reduced cell adhesion, spreading and extension of actin stress fibers on dishes coated with fibronectin but not on dishes coated with collagen. Phosphorylation levels of FAK in U251-DN cells were also attenuated on dishes coated with fibronectin. Reduced expression level of integrin α5 subunit in U251-DN cells was demonstrated by semi-quantitative RT-PCR analysis. Furthermore, down-regulation of transcription from the integrin α5 promoter by expression of Ets-DN was shown by luciferase reporter assay. Semi-quantitative RT-PCR of surgical samples of brain tumors revealed that the expression level of Ets-1 mRNA correlated with that of integrin α5 mRNA in glioma. These results suggest that Ets-1 contributes to glioma malignancy by upregulating expression of the integrin α5 subunit, which composes integrin α5β1, mediates intracellular signaling and the subsequent acceleration of the invasive process including cell adhesion and migration.
期刊论文(34)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
I, Kita D, Et al: "Ets-1 positively regulates expression of urokinase-type plasminogen activator(uPA)and invasiveness of astrocytic tumors."Cancer Res. (in press).
I、Kita D 等人:“Ets-1 正向调节尿激酶型纤溶酶原激活剂 (uPA) 的表达和星形细胞肿瘤的侵袭性。”Cancer Res。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nakada M: "Roles of membrane-type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma."J Neurosurg. 94. 464-473 (2001)
Nakada M:“膜型 1 型基质金属蛋白酶和金属蛋白酶 2 组织抑制剂在人类恶性神经胶质瘤的侵袭和扩散中的作用。”神经外科杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nakada M: "Ets-1 positively regulates expression of urokinase-type plasminogen activator(uPA)and invasiveness of astrocytic tumors."J Neuropathol Exp Neurol. 58. 329-334 (1999)
Nakada M:“Ets-1 正向调节尿激酶型纤溶酶原激活剂 (uPA) 的表达和星形细胞肿瘤的侵袭性。”J Neuropathol Exp Neurol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nakada M: "Expression and tissue localization of membrane types 1, 2 and 3 matrix metalloproteinases in human astrocytic tumors"Am J Pathol. 154. 417-428 (1999)
Nakada M:“人星形细胞肿瘤中 1、2 和 3 型膜基质金属蛋白酶的表达和组织定位”Am J Pathol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nakada, M: "Ets-1 positively regulates expression urokinase-type plasminogen activator (uPA) and invasiveness of astrocytic tumors"J Neuropathol Exp Neurol. 58. 329-334 (1999)
Nakada, M:“Ets-1 正向调节尿激酶型纤溶酶原激活剂 (uPA) 的表达和星形细胞肿瘤的侵袭性”J Neuropathol Exp Neurol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 14 条
The analysis of transcription factor and ECM degradation enzyme associated with invasion of glioblastoma
-
批准号:13470290
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.96万
-
财政年份:2001
-
负责人:YAMASHITA Junkoh
-
依托单位:
Analysis of cell death inducing gene in human malignant gliomas
-
批准号:09470292
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.03万
-
财政年份:1997
-
负责人:YAMASHITA Junkoh
-
依托单位:
Inhibition of Gene Expression from the Human c-erb B Gene Promoter by a Retroviral Vector Expressing Anti-gene RNA
-
批准号:07457310
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.54万
-
财政年份:1995
-
负责人:YAMASHITA Junkoh
-
依托单位:
Development of chemokine-expressing retrovirus vector system in malignant gliomas
-
批准号:07557359
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$1.41万
-
财政年份:1995
-
负责人:YAMASHITA Junkoh
-
依托单位:
INHIBITION OF TRANSCRIPTION OF THE HUMAN EGFR GENE IN GLIOMA BY SITE-SPECIFIC OLIGONUCLEOTIDES DESIGNED TO FORM DNA TRIPLE HELICES
-
批准号:05454395
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.22万
-
财政年份:1993
-
负责人:YAMASHITA Junkoh
-
依托单位:
Adoptive Immunotherapy for Malignant Brain Tumors Using Killer T Lymphocytes Enhanced by Interferon Gamma Gene Transfer
-
批准号:62480307
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.9万
-
财政年份:1987
-
负责人:YAMASHITA Junkoh
-
依托单位:
国内基金
海外基金
登录
查看更多内容
泛素连接酶TRIM65通过RhoGAP调控Rho活性促进结直肠癌侵袭转移的分子机制
-
批准号:31970703
-
项目类别:面上项目
-
资助金额:50.0万元
-
批准年份:2019
-
负责人:陈代词
-
依托单位:
幽门螺杆菌感染促进肿瘤相关成纤维细胞与胃癌细胞的互作及机制研究
-
批准号:31760328
-
项目类别:地区科学基金项目
-
资助金额:36.0万元
-
批准年份:2017
-
负责人:周建奖
-
依托单位:
LncRNA-GMAN调控胃癌细胞侵袭和转移的分子作用机制研究
-
批准号:31771540
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2017
-
负责人:卓巍
-
依托单位:
Hedgehog通路调控长链非编码RNA对胰腺癌增殖侵袭的影响及机制研究
-
批准号:81172184
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2011
-
负责人:杨尹默
-
依托单位:
MDR1与Anxa2相互作用调节耐药乳腺癌细胞侵袭的分子机制研究
-
批准号:81071731
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2010
-
负责人:牛瑞芳
-
依托单位:
南美蟛蜞菊入侵对土壤微生物的影响及反馈作用
-
批准号:30970556
-
项目类别:面上项目
-
资助金额:40.0万元
-
批准年份:2009
-
负责人:杜道林
-
依托单位:
与肺癌细胞侵袭相关的microRNAs研究
-
批准号:30771187
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2007
-
负责人:罗泽伟
-
依托单位:
柔嫩艾美耳球虫侵入宿主细胞的分子机制
-
批准号:30500370
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2005
-
负责人:李建华
-
依托单位: